Reckitt Benckiser Group plc (OTCMKTS:RBGLY – Get Free Report) saw a significant increase in short interest in the month of September. As of September 15th, there was short interest totalling 484,000 shares, an increase of 127.8% from the August 31st total of 212,500 shares. Based on an average trading volume of 664,100 shares, the days-to-cover ratio is currently 0.7 days.
Analyst Upgrades and Downgrades
A number of equities research analysts have recently commented on the stock. JPMorgan Chase & Co. lowered shares of Reckitt Benckiser Group from an “overweight” rating to a “neutral” rating in a research note on Thursday, August 29th. UBS Group raised shares of Reckitt Benckiser Group to a “strong-buy” rating in a research report on Wednesday, September 18th. One investment analyst has rated the stock with a sell rating, five have given a hold rating, one has assigned a buy rating and one has given a strong buy rating to the company’s stock. According to data from MarketBeat.com, the stock currently has an average rating of “Hold” and an average target price of $7,400.00.
Check Out Our Latest Report on RBGLY
Reckitt Benckiser Group Price Performance
Reckitt Benckiser Group Cuts Dividend
The business also recently announced a dividend, which was paid on Monday, September 23rd. Investors of record on Monday, August 5th were paid a dividend of $0.1915 per share. The ex-dividend date was Monday, August 5th.
Reckitt Benckiser Group Company Profile
Reckitt Benckiser Group plc manufactures and sells health, hygiene, and nutrition products worldwide. It offers acne treatment creams, facial washes, and cleansing pads; germ protection products; condoms; heartburn and indigestion solutions; joints health products; chest congestion, cough, and sinus remedies; brain health products; migraine-headaches and rheumatic pain products; sore throat medications; and hair removal products under the Airborne, Clearasil, Dettol, Durex, Gaviscon, Move Free, Neuriva, Nurofen, Mucinex, Strepsils, and Veet brands.
Recommended Stories
- Five stocks we like better than Reckitt Benckiser Group
- Profitably Trade Stocks at 52-Week Highs
- CarMax’s Impressive Rally: What Investors Should Watch Next
- Insider Buying Explained: What Investors Need to Know
- MarketBeat Week in Review – 9/23 – 9/27
- How to buy stock: A step-by-step guide for beginners
- Wake Up to This Biotech Stock That Still Has Big Potential Upside
Receive News & Ratings for Reckitt Benckiser Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Reckitt Benckiser Group and related companies with MarketBeat.com's FREE daily email newsletter.